- Home
- KNSA vs DBD Comparison
KNSA vs DBD Comparison
Compare KNSA & DBD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KNSA | DBD |
|---|---|---|
| Founded | 2015 | 1859 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.5B | 3.0B |
| IPO Year | 2018 | 2023 |
Fundamental Metrics
Financial Performance| Metric | KNSA | DBD |
|---|---|---|
| Price | $53.51 | $74.41 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 3 |
| Target Price | $60.86 | ★ $90.00 |
| AVG Volume (30 Days) | ★ 689.2K | 284.1K |
| Earning Date | 04-28-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 225.00 | ★ 677.27 |
| EPS | ★ 0.27 | 0.14 |
| Revenue | $677,564,000.00 | ★ $3,805,700,000.00 |
| Revenue This Year | $37.48 | $3.56 |
| Revenue Next Year | $17.87 | $3.25 |
| P/E Ratio | ★ $199.89 | $514.54 |
| Revenue Growth | ★ 60.09 | 1.46 |
| 52 Week Low | $26.27 | $47.34 |
| 52 Week High | $59.87 | $89.05 |
Technical Indicators
Market Signals| Indicator | KNSA | DBD |
|---|---|---|
| Relative Strength Index (RSI) | 51.48 | 46.26 |
| Support Level | $40.67 | $72.37 |
| Resistance Level | $59.87 | $84.96 |
| Average True Range (ATR) | 2.10 | 2.30 |
| MACD | -0.74 | -0.32 |
| Stochastic Oscillator | 17.59 | 50.63 |
Price Performance
Historical ComparisonAbout KNSA Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating cardiovascular diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and Vixarelimab. Geographically, the company earns maximum revenue from United States.
About DBD Diebold Nixdorf Incorporated
Diebold Nixdorf Inc is engaged in providing software and hardware services for financial and retail industries. The customer segments of the company are Banking, which offers integrated solutions for financial institutions, and Retail, which offers solutions, software, and services that improve the checkout process for retailers. A majority of its revenue is generated from the Banking segment.